
Alnylam Pharmaceuticals Inc (ALNY)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 59.56B
P/E Ratio
0.00
Revenue (TTM)
$ 2.46B
Volume
0
52W High
$ 469.81
52W Low
$ 205.87
Dividend Yield
0.00%
Beta
0.25
Technicals
50-Day MA
360.0136
200-Day MA
284.2611
52 Week High
469.81
52 Week Low
205.87
About ALNY
Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.
Employees
2230
Headquarters
Cambridge, MA
CEO
Dr. Yvonne L. Greenstreet M.B.A., M.D.
Latest News
Alnylam (ALNY) Reports Q4 Earnings: What Key Metrics Have to Say - MSN
2 days ago • Google News
Earnings Estimates Rising for Alnylam (ALNY): Will It Gain? - Yahoo Finance
4 weeks ago • Google News